Rights and permissions
About this article
Cite this article
Monitoring early viral response to PEG IFN-α-2b + ribavirin warranted. Pharmacoecon. Outcomes News 443, 9 (2003). https://doi.org/10.1007/BF03277205
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03277205